From 1997 to 2020, the prevalence of obesity in the adult population increased steadily in France. However, obesity rates have grown unequally among different age groups. From 1997 to 2020, the share of obese people was higher among older people. In 2020, roughly ** percent of people aged 55 to 64 suffered from obesity in France.

These figures revealed one exception among the eldest age group. Indeed, among French people aged 65 or older, obesity prevalence decreased from 2012 to 2020. As a result, during this period, obesity rates among 55-64 year olds surpassed that among ** and over ** year olds.

This statistic displays the prevalence of adolescent obesity* in France from 1975 to 2016, by gender. In 1975, the prevalence of obesity among French adolescents showed no gender differences. While the obesity rate has increased for both male and female adolescents over the intervening years, male adolescents in France were more likely to be obese than female adolescents as of 2016.

In 2020, the prevalence of obesity in the adult population stood at ** percent in France, yet varied greatly from one region to another. During that year, obesity prevalence ranged from ** percent, in Ile-de-France, to over ** percent, in Hauts-de-France. Interestingly, the two regions with the second and third highest obesity rates were also northern, Normandie and Grand-Est.

Historical dataset showing France obesity rate by year from N/A to N/A.

From 1997 to 2020, the prevalence of obesity in the adult population increased steadily in France. In 1997, less than **** percent of adults were obese in France. By 2020, the prevalence of obesity had increased to ** percent. At this rate, obesity could soon touch *** in **** adults in France.

This statistic displays the prevalence of childhood obesity* in France from 1975 to 2016, by gender. Since the beginning of this time series, there has been a greater prevalence of childhood obesity among male children in France than among females.

In 2019, Prevalence of Overweight in Tuvalu increased 0.6points from a year earlier.

From 1997 to 2020, the prevalence of overweight and obesity in the adult population increased steadily in France. In 1997, over ** percent of adults were overweight or obese in France. By 2020, the prevalence of obesity had increased to ** percent. However, the share of overweight and obesity in France remained stable from 2012 to 2020.

The France Bariatric Surgery Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 13.2% during the forecast period, 2023 – 2031. The growth of market is attributed to increasing number of stout patients in the population and ubiquitous rate of Type-2 heart and diabetic diseases.

The major cause of obesity is metabolic dysfunction and a wide range of chronic illness associated with it that becomes the significant cause of increase in mortality rates. The factors such as misbalance of quality of life, considerable amount of healthcare, and premature mortality are found majorly in the patients suffering from obesity.

The diseases associated with obesity includes stroke, sleep apnea, osteoarthritis, hypertension, and Type-2 diabetes, thus obesity is undoubtedly considered as one of the primary cause of diabetes and by far bariatric surgery is been one of the most efficient method to control both.



According to 2019 report of organization of economic co-operation and development (OECD), every 1 out of 10^th person in France, and approximately 40% of the Frances’ population is overweight or suffering from obesity, furthermore it is clear indication that in the coming years the overweight rates will escalate by 10% or even more.



Moreover with the sudden appearance of new and advance technologies in bariatric surgery segment and increasing demand for minimally invasive surgical process is anticipated to augment the market growth in the coming years. Bariatric procedure is witnessing a drastic demand increase in France which is expected to double the growth in the European market.

Market Trends, Drivers, Restraints, and Opportunities

• 
  

  Increasing obese population and rising prevalence of heart and diabetes diseases is expected to propel the market during the forecast period.

  
  


• 
  

  <span style=&quo

France Bariatric Surgery Market size was valued at USD 1.32 Billion in 2024 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 9.1% from 2024 to 2031.

France Bariatric Surgery Market Drivers

Rising Obesity Rates: The increasing prevalence of obesity in France is a major driver of the bariatric surgery market. According to the French National Institute for Health and Medical Research (INSERM), over 17% of the adult population in France is classified as obese, with numbers continuing to rise. A growing number of people are considering bariatric surgery as a therapeutic option to enhance their quality of life and avoid additional health risks because obesity causes a number of health issues, including diabetes, cardiovascular illnesses, and insomnia. Government Initiatives and Healthcare Funding: The French government has been actively investing in healthcare to combat the growing obesity epidemic. A larger population now has easier access to bariatric surgery because to France's recent expansion of its national health insurance coverage for the treatment. In 2022, the French Ministry of Health announced plans to increase funding for bariatric surgeries as part of its strategy to reduce obesity-related health burdens, thus providing a boost to the market. Technological Advancements in Surgical Procedures: Advancements in surgical technologies, particularly minimally invasive techniques such as laparoscopic and robotic-assisted surgeries, are contributing to the growth of the bariatric surgery market in France. These methods give patients less wounds, fewer problems, and quicker recovery times. More sophisticated robotic technologies, such as the da Vinci Surgical System, have improved the accuracy and security of bariatric procedures, making them more desirable to patients and surgeons alike. Growing Awareness and Acceptance of Bariatric Surgery: Increased awareness about obesity and the benefits of bariatric surgery is also driving market growth. The demand for bariatric surgery is rising as more patients become aware of the benefits of these treatments, including significant weight loss and a reduction in comorbidities associated with obesity.

BackgroundGrowth charts are an essential clinical tool for evaluating a child's health and development. The current French reference curves, published in 1979, have recently been challenged by the 2006 World Health Organization (WHO) growth charts.ObjectiveTo evaluate and compare the growth of French children who were born between 1981 and 2007, with the WHO growth charts and the French reference curves currently used.DesignAnthropometric measurements from French children, who participated in 12 studies, were analyzed: 82,151 measurements were available for 27,257 children in different age groups, from birth to 18 years. We calculated and graphically compared mean z-scores based on the WHO and French curves, for height, weight and Body Mass Index (BMI) according to age and sex. The prevalence of overweight using the WHO, the French and International Obesity Task Force definitions were compared.ResultsOur population of children was on average 0.5 standard deviations taller than the French reference population, from the first month of life until puberty age. Mean z-scores for height, weight and BMI were closer to zero based on the WHO growth charts than on the French references from infancy until late adolescence, except during the first six months. These differences not related to breastfeeding rates. As expected, the prevalence of overweight depended on the reference used, and differences varied according to age.ConclusionThe WHO growth charts may be appropriate for monitoring growth of French children, as the growth patterns in our large population of French children were closer to the WHO growth charts than to the French reference curves, from 6 months onwards. However, there were some limitations in the use of these WHO growth charts, and further investigation is needed.

As of 2020, roughly *** out of two adults were overweight or obese in France. During that year, around ** percent of French adults had a BMI of over **, which the index classifies as overweight. Nonetheless, only ** percent of adults fell under the obesity classification: a BMI of at least **.

Snapshot img

Weight Management Market Size 2025-2029

The weight management market size is forecast to increase by USD 114.79 billion at a CAGR of 10.9% between 2024 and 2029.

The market is driven by the growing obese population and rising demand for weight management services from developing economies. The increasing prevalence of obesity and related health issues globally presents a significant opportunity for market participants. However, marketing challenges associated with weight management products and services pose a significant hurdle. The stigma surrounding obesity and the perception that weight loss is a personal responsibility rather than a health issue create barriers to market penetration. Health insurance plays a pivotal role in covering costs, while fitness apps and mobile health apps enhance accessibility and tracking.
Companies seeking to capitalize on market opportunities must address these challenges through innovative marketing strategies, affordable pricing, and education initiatives to shift societal perceptions and increase accessibility to weight management services. By focusing on these areas, market participants can effectively navigate challenges and capitalize on the growing demand for weight management solutions. Innovative weight management solutions include waistline control, fitness equipment, surgical equipment, healthy dietary choices, and lifestyle changes.

What will be the Size of the Weight Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market for weight management solutions continues to evolve, reflecting the complex and multifaceted nature of weight management and its applications across various sectors. Sleeve gastrectomy and adjustable gastric banding are among the surgical interventions, while anti-obesity medications and pharmacological interventions offer alternative approaches. The prevalence of metabolic syndrome and its associated health risks, including cardiovascular disease and type 2 diabetes, underscores the urgency for sustainable weight loss solutions. Mindful eating, nutrition education, and meal planning are essential components of health behavior modification, while physical fitness and regular exercise routines contribute to weight regain prevention. Fitness and recreational sports centers are offering a wide range of HIIT classes, and HIIT fitness videos are flooding the market.

Hormonal imbalance and stress management are also crucial factors in weight management. The industry is expected to grow by 5.3% annually, driven by the increasing prevalence of obesity and related health issues. For instance, a study showed that patients who underwent bariatric surgery experienced an average weight loss of 30% within the first year. Social media and the young population's hectic lifestyles have led to increased fast food consumption and weight-related health issues, necessitating preventive measures and weight management programs. Additionally, the complexity and cost of weight management solutions can deter potential customers, particularly in developing economies with limited resources.

How is this Weight Management Industry segmented?

The weight management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Diet
  Equipment
  Services


Distribution Channel

  Offline
  Online


End-user

  Fitness centers and health clubs
  Commercial weight loss centers
  Online weight loss programs
  Slimming centers
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Type Insights

The Diet segment is estimated to witness significant growth during the forecast period. The market is driven by the growing concern over health issues related to visceral fat, weight fluctuation, and obesity. Obesity, characterized by a body mass index (BMI) of 30 or higher, affects over one-third of the global population. This condition can lead to various health complications, including high blood pressure, joint problems, diabetes, and insulin sensitivity issues. To combat these health concerns, weight loss programs focusing on calorie expenditure through diet and physical activity have gained popularity. Diets, specifically, dominate the market, as they offer a more sustainable approach to weight management. Nutritional counseling and micronutrient intake are essential components of effective weight loss programs, ensuring a balanced macronutrient and micronutrient intake. Obesity rates continue to rise, fueling the demand for

The France bariatric surgery market, valued at approximately €200 million in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 13.20% from 2025 to 2033. This expansion is driven by several key factors. The rising prevalence of obesity and related comorbidities like type 2 diabetes and cardiovascular disease in France is a significant catalyst. Increased awareness of bariatric surgery as an effective weight-loss solution, coupled with improved surgical techniques and technological advancements in minimally invasive procedures, is further fueling market growth. Furthermore, supportive government initiatives aimed at combating obesity and promoting better healthcare outcomes are contributing to the market's positive trajectory. The market segmentation reveals a strong demand for assisting devices, particularly suturing, closure, and stapling devices, reflecting the technological sophistication of modern bariatric procedures. The implantable devices segment, while smaller, is expected to show significant growth due to innovations in gastric bands and electrical stimulation devices. Leading players like Johnson & Johnson (Ethicon Inc.), Medtronic PLC (Covidien), and Apollo Endosurgery Inc. are actively driving innovation and expanding their market presence through strategic partnerships and technological advancements. However, the market faces some challenges. High procedure costs and limited insurance coverage can restrict access to bariatric surgery for a considerable portion of the population. Potential complications associated with the procedures and the need for long-term post-operative care also represent constraints on market growth. Despite these limitations, the overall outlook for the France bariatric surgery market remains optimistic, with continuous innovation in surgical techniques and devices poised to overcome many of these challenges and further drive market expansion over the forecast period. The strong focus on improving patient outcomes and the increasing prevalence of obesity will remain key drivers. The competitive landscape is characterized by both established multinational corporations and specialized medical device manufacturers, leading to ongoing innovation and market evolution. Recent developments include: July 2022: University Hospital, Bordeaux sponsored a clinical study on the effectiveness of the use of VERT on improving body image at 12 months in patients who underwent bariatric surgery in the weight stabilization phase. The study is expected to be completed by 2024., February 2022: Assistance Publique - Hopitaux de Paris sponsored a clinical study aiming to assess the impact of surgical bariatric treatment on the improvement of pancreatic lesions detected by magnetic resonance imaging (MRI) in France.. Key drivers for this market are: Increase in Obese Patients, Government Initiatives to Curb Obesity. Potential restraints include: Increase in Obese Patients, Government Initiatives to Curb Obesity. Notable trends are: Stapling Devices Segment is Expected to Grow Significantly over the Forecast Period.

France nutritional supplements market is valued at USD 5.3 billion, driven by health awareness, preventive healthcare, and rising obesity rates, with strong demand in cities like Paris and Lyon.

Background: In Europe, although the prevalence of childhood obesity seems to be plateauing in some countries, progress on tackling this important public health issue remains slow and inconsistent. Breastfeeding has been described as a protective factor, and the more exclusively and the longer children are breastfed, the greater their protection from obesity. Birth weight has been shown to have a positive association with later risk for obesity. Objectives: It was the aim of this paper to investigate the association of early-life factors, namely breastfeeding, exclusive breastfeeding and birth weight, with obesity among children. Method: Data from 22 participating countries in the WHO European COSI study (round 4: 2015/2017) were collected using cross-sectional, nationally representative samples of 6- to 9-year-olds (n = 100,583). The children’s standardized weight and height measurements followed a common WHO protocol. Information on the children’s birth weight and breastfeeding practice and duration was collected through a family record form. A multivariate multilevel logistic regression analysis regarding breastfeeding practice (both general and exclusive) and characteristics at birth was performed. Results: The highest prevalence rates of obesity were observed in Spain (17.7%), Malta (17.2%) and Italy (16.8%). A wide between-country disparity in breastfeeding prevalence was found. Tajikistan had the highest percentage of children that were breastfed for ≥6 months (94.4%) and exclusively breastfed for ≥6 months (73.3%). In France, Ireland and Malta, only around 1 in 4 children was breastfed for ≥6 months. Italy and Malta showed the highest prevalence of obesity among children who have never been breastfed (21.2%), followed by Spain (21.0%). The pooled analysis showed that, compared to children who were breastfed for at least 6 months, the odds of being obese were higher among children never breastfed or breastfed for a shorter period, both in case of general (adjusted odds ratio [adjOR] [95% CI] 1.22 [1.16–1.28] and 1.12 [1.07–1.16], respectively) and exclusive breastfeeding (adjOR [95% CI] 1.25 [1.17–1.36] and 1.05 [0.99–1.12], respectively). Higher birth weight was associated with a higher risk of being overweight, which was reported in 11 out of the 22 countries. Bulgaria, Croatia, France, Italy, Poland and Romania showed that children who were preterm at birth had higher odds of being obese, compared to children who were full-term babies. Conclusion: The present work confirms the beneficial effect of breastfeeding against obesity, which was highly increased if children had never been breastfed or had been breastfed for a shorter period. Nevertheless, adoption of exclusive breastfeeding is below global recommendations and far from the target endorsed by the WHO Member States at the World Health Assembly Global Targets for Nutrition of increasing the prevalence of exclusive breastfeeding in the first 6 months up to at least 50% by 2025.

From 1997 to 2020, the prevalence of obesity in the adult population increased steadily in France. However, obesity rates have unequally grown among men and women. From 1997 to 2003, the share of obese men was higher than that of women. In 1997, roughly *** percent of men were obese in France, compared to *** percent of women. By 2006, the prevalence of obesity among French women was higher than for men. In 2020, roughly **** percent of men and **** percent of women suffered from obesity in France.

France Food Sweetener Market size is expected to develop revenue and exponential market growth at a remarkable CAGR from 2026 to 2032.

Key Market Drivers:

Health Consciousness: Growing awareness of the health risks associated with excessive sugar consumption is driving consumers to seek healthier alternatives. This trend is reflected in the increasing demand for low-calorie and sugar-free sweeteners, as more individuals prioritize their health and well-being.

Rising Obesity Rates: The increasing prevalence of obesity in France has led to a greater adoption of low-calorie sweeteners. According to the French National Institute for Health and Medical Research, approximately 17% of adults were classified as obese in 2022, prompting a shift towards healthier dietary choices.

The European weight loss surgery market is experiencing robust growth, driven by rising obesity rates, increasing awareness of bariatric procedures, and advancements in minimally invasive surgical techniques. The market, valued at approximately €X million in 2025 (assuming a logical extrapolation based on the provided CAGR of 15% and the unspecified market size "XX" – a precise figure requires the missing "XX" value), is projected to reach €Y million by 2033. This significant expansion is fueled by several key factors. The increasing prevalence of obesity and related comorbidities like type 2 diabetes and cardiovascular disease is creating a substantial demand for effective weight loss solutions. Furthermore, technological advancements in devices such as suturing devices, stapling devices, and implantable gastric bands are leading to safer, less invasive procedures with improved patient outcomes, driving market penetration. The segment of assisting devices, encompassing suturing, closure, and stapling devices, is expected to dominate the market due to its widespread use in various bariatric surgeries. However, the growth is also influenced by factors like high procedure costs, potential complications associated with surgery, and varying reimbursement policies across European countries. Growth across the major European markets – Germany, the United Kingdom, France, Italy, and Spain – will contribute significantly to the overall market expansion. However, disparities in healthcare infrastructure and insurance coverage may lead to regional variations in adoption rates. The competitive landscape includes established players like Allergan, Ethicon, and Covidien, as well as emerging companies focusing on innovative technologies. These companies are constantly investing in research and development to introduce advanced devices and improve surgical techniques, further propelling the market's growth. While regulatory hurdles and potential risks associated with weight loss surgery present challenges, the overall outlook for the European weight loss surgery market remains positive, indicating substantial growth opportunities over the forecast period. (Note: 'X' and 'Y' represent calculated values derived from the 15% CAGR and the missing base market size. To obtain precise figures, the missing market size data is required). Recent developments include: In June 2022, Rhythm Pharmaceuticals, Inc. announced that IMCIVREE is available to patients in Germany.The European Commission granted IMCIVREE marketing authorization for the treatment of obesity and the management of hunger in adults and children aged 6 and older with genetically confirmed loss-of-function biallelic pro-opiomelanocortin, including proprotein convertase subtilisin/kexin type 1 deficiency or biallelic leptin receptor deficiency., In June 2022, European Medicines Agency (EMA) safety committee Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the withdrawal of European Union (EU) marketing authorisations for amfepramone obesity medicines.. Key drivers for this market are: Increase in Obese Population, Prevalence of Diabetes and Heart Diseases; Government Initiatives to Curb Obesity; Insurance Coverage of Surgeries. Potential restraints include: Increase in Obese Population, Prevalence of Diabetes and Heart Diseases; Government Initiatives to Curb Obesity; Insurance Coverage of Surgeries. Notable trends are: Gastric Balloons Segment is Expected to Witness the Highest CAGR in the Market Over the Forecast Period.

Prescription Diet Pet Food Market Outlook

The global prescription diet pet food market size reached approximately USD 9.8 billion in 2023 and is projected to grow to USD 15.6 billion by 2032, exhibiting a CAGR of around 5.1% during the forecast period. This growth is driven by increasing pet ownership, rising awareness about pet health, and the humanization of pets leading to higher spending on specialized pet foods.

The prescription diet pet food market is experiencing significant growth due to a variety of factors. One of the primary drivers is the increasing prevalence of chronic diseases in pets, such as obesity, diabetes, and kidney issues. As pets age, they become more susceptible to such ailments, which in turn drives up the demand for specialized, therapeutic diets designed to manage these conditions. Owners are becoming more mindful of their pets' health, which has led to a surge in veterinary visits where prescription diets are often recommended. This trend is further amplified by the increasing availability of advanced diagnostic tools that make it easier to identify specific health issues in pets.

Another key growth factor is the rise in disposable incomes globally. As people have more disposable income, they are more willing to spend on premium products for their pets, including prescription diet foods. The humanization of pets has led to owners treating their pets more like family members, which includes a focus on their health and nutrition. This cultural shift is noticeable in both developed and emerging markets, where pet owners are increasingly opting for specialized diets that claim to offer health benefits and improved longevity for their pets.

Technological advancements in pet food manufacturing are also playing a significant role. Innovations in food processing and ingredient sourcing have made it possible to create highly specialized and effective prescription diets that cater to a wide range of health conditions. Companies are investing heavily in research and development to formulate diets that can effectively manage or even prevent certain health issues. This has led to a broadening of the market as new products are continually introduced, catering to the specific needs of pets.

Regionally, North America remains a significant market due to the high rate of pet ownership and a strong focus on pet healthcare. Europe follows closely behind, with countries like the UK, Germany, and France showing high adoption rates for prescription diets. The Asia Pacific region is also emerging as a significant market due to rising disposable incomes and increasing awareness about pet health. Latin America and the Middle East & Africa are still developing markets but show promising growth potential as pet ownership rises and awareness about pet health improves.

Pet Type Analysis

The prescription diet pet food market is segmented by pet type, including dogs, cats, and others. Among these, the dog segment holds the largest market share. Dogs are more prone to specific health conditions such as obesity, arthritis, and allergies, making the demand for prescription diets particularly high. Owners are increasingly seeking specialized diets that can help manage these conditions, leading to a surge in the production and sale of dog-specific prescription diets. Moreover, dogs often require more food than cats, which further drives up the demand in this segment.

On the other hand, the cat segment is also witnessing significant growth. Cats have their own set of health issues, such as urinary tract infections, kidney disease, and obesity, which necessitate specialized diets. The growing awareness among cat owners regarding these issues is driving the demand for prescription diets tailored specifically for cats. Companies are responding by developing a wide range of cat-specific prescription foods that address these health concerns, thereby expanding the market.

The "others" category includes small mammals, birds, and exotic pets. While this segment holds a smaller share compared to dogs and cats, it is growing steadily. The increasing trend of owning exotic pets and the rising awareness about their specific nutritional needs are contributing to the growth of this segment. Specialized diets for these animals are becoming more available, although the market remains niche compared to dogs and cats.

Overall, the segmentation by pet type highlights the diverse needs of different animals and the market's ability to cater to these needs through specialized diets. The f